Skip to main content

previous disabled Page of 4
and
  1. No Access

    Article

    Introductory Overview

    Klaus Pantel in Cancer and Metastasis Reviews (1999)

  2. No Access

    Article

    Biological Characteristics of Micrometastatic Cancer Cells in Bone Marrow

    There is emerging evidence that epithelial tumor cells are able to disseminate to secondary organs at an early stage of primary tumor development. One of the most prominent secondary organs screened for this t...

    Stephan Braun, Klaus Pantel in Cancer and Metastasis Reviews (1999)

  3. No Access

    Reference Work Entry In depth

    Micrometastasis

    Klaus Pantel in Encyclopedic Reference of Cancer (2001)

  4. No Access

    Article

    Dissecting the metastatic cascade

  5. In some solid tumours, such as those of the head and neck, the presence of lymph-node metastases is closely linked to the development of distant metastases. In...

  6. Klaus Pantel, Ruud H. Brakenhoff in Nature Reviews Cancer (2004)

  7. Article

    Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives

    Early tumor cell dissemination at the single-cell level can be revealed in patients with breast cancer by using sensitive immunocytochemical and molecular assays. Recent clinical studies involving more than 40...

    Volkmar Müller, Klaus Pantel in Breast Cancer Research (2004)

  8. No Access

    Article

    Molecular mechanisms of metastasis

    A major topic covered at the First International Symposium on Cancer Metastasis and the Lymphovascular System was the molecular mechanisms of metastasis. This has become of major interest in recent years as we...

    Dave S. B. Hoon, Minoru Kitago, Joseph Kim, Takuji Mori in Cancer and Metastasis Reviews (2006)

  9. Article

    Recent translational research: circulating tumor cells in breast cancer patients

    In breast cancer patients, hematogenous tumor cell dissemination can be detected, even at the single cell level, by applying immunocytochemical and molecular assays. Various methods for the detection of circul...

    Volkmar Müller, Daniel F Hayes, Klaus Pantel in Breast Cancer Research (2006)

  10. Article

    Open Access

    A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer

    The aim of the study was to perform a comparative analysis of LOH (loss of heterozygosity) in primary tumors as well as peripheral blood and bone marrow (BM) of patients with breast cancer (BCa).

    Heidi Schwarzenbach, Volkmar Müller, Cord Beeger, Miriam Gottberg in Breast Cancer Research (2007)

  11. No Access

    Chapter

    Prostate Cancer: Detection of Free Tumor-Specific DNA in Blood and Bone Marrow

    Prostate carcinoma is one of the most frequently diagnosed cancer types in men. If diagnosed at an early stage, prostate cancer is usually treatable. For a patient with a clinically localized tumor, the primar...

    Heidi Schwarzenbach, Klaus Pantel in General Methods and Overviews, Lung Carcin… (2008)

  12. Article

    Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

    Immunocytochemical or molecular assays allow the detection of single disseminated tumor cells (DTCs) in the bone marrow (BM) or the peripheral blood in 10% to 60% of breast cancer patients without signs of met...

    Tanja Fehm, Volkmar Müller, Catherine Alix-Panabières in Breast Cancer Research (2008)

  13. No Access

    Article

    Detection, clinical relevance and specific biological properties of disseminating tumour cells

  14. Tumour cell dissemination is an early event in tumorigenesis and is relevant for metastatic progression (in particular for breast cancer). These data have led ...

  15. Klaus Pantel, Ruud H. Brakenhoff, Burkhard Brandt in Nature Reviews Cancer (2008)

  16. No Access

    Reference Work Entry In depth

    Micrometastasis

    Catherine Alix-Panabieres, Klaus Pantel in Encyclopedia of Cancer (2009)

  17. Article

    Open Access

    Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

    We evaluated whether CK19, one of the main cytoskeleton proteins of epithelial cells, is released as full-length protein from viable tumor cells and whether this property is relevant for metastatic progression...

    Catherine Alix-Panabières, Jean-Pierre Vendrell, Monique Slijper in Breast Cancer Research (2009)

  18. Article

    Open Access

    Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

    The origin and clinical relevance of circulating cell-free tumor DNA in the blood of cancer patients is still unclear. Here we investigated whether the detection of this DNA is related to bone marrow (BM) micr...

    Heidi Schwarzenbach, Klaus Pantel, Birthe Kemper, Cord Beeger in Breast Cancer Research (2009)

  19. Article

    Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients

    Sabine Riethdorf, Klaus Pantel in Breast Cancer Research (2009)

  20. Article

    Open Access

    Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by Methyl-CpG binding proteins and histone modifications

    The aim of the current study was to analyze the involvement of methyl-CpG binding proteins (MBDs) and histone modifications on the regulation of CD44, Cyclin D2, GLIPR1 and PTEN in different cellular contexts ...

    Imke Müller, Frank Wischnewski, Klaus Pantel, Heidi Schwarzenbach in BMC Cancer (2010)

  21. Article

    What's new on circulating tumor cells? A meeting report

    Circulating tumor cells (CTCs) provide unique information for the management of cancer patients. The 7th International Symposium on Minimal Residual Cancer has focused on state of the art research, including e...

    Evi S Lianidou, Dimitris Mavroudis, Georgia Sotiropoulou in Breast Cancer Research (2010)

  22. Article

    Open Access

    Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

    MicroRNAs (miRs) are interesting new diagnostic targets that may provide important insights into the molecular pathogenesis of breast cancer. Here we evaluated, for the first time, the feasibility and clinical...

    Carina Roth, Brigitte Rack, Volkmar Müller, Wolfgang Janni in Breast Cancer Research (2010)

  23. No Access

    Reference Work Entry In depth

    Micrometastasis

    Catherine Alix-Panabieres, Klaus Pantel in Encyclopedia of Cancer (2011)

  24. No Access

    Chapter and Conference Paper

    Increase in Circulating MicroRNA Levels in Blood of Ovarian Cancer Patients

    Since their functional role in tumour biology is to a large extent unknown, the focus of the current study is the extraction and quantification of circulating microRNAs. Using serum of patients with ovarian ca...

    Carina Roth, Sabine Kasimir-Bauer in Circulating Nucleic Acids in Plasma and Se… (2011)

previous disabled Page of 4